BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 27452207)

  • 1. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association.
    Katchamart W; Narongroeknawin P; Chevaisrakul P; Dechanuwong P; Mahakkanukrauh A; Kasitanon N; Pakchotanon R; Sumethkul K; Ueareewongsa P; Ukritchon S; Bhurihirun T; Duangkum K; Intapiboon P; Intongkam S; Jangsombatsiri W; Jatuworapruk K; Kositpesat N; Leungroongroj P; Lomarat W; Petcharat C; Sittivutworapant S; Suebmee P; Tantayakom P; Tipsing W; Asavatanabodee P; Chiowchanwisawakit P; Foocharoen C; Koolvisoot A; Louthrenoo W; Siripaitoon B; Totemchokchyakarn K; Kitumnuaypong T;
    Int J Rheum Dis; 2017 Sep; 20(9):1142-1165. PubMed ID: 27452207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
    Louthrenoo W; Kasitanon N; Katchamart W; Aiewruengsurat D; Chevaisrakul P; Chiowchanwisawakit P; Dechanuwong P; Hanvivadhanakul P; Mahakkanukrauh A; Manavathongchai S; Muangchan C; Narongroeknawin P; Phumethum V; Siripaitoon B; Suesuwan A; Suwannaroj S; Uea-Areewongsa P; Ukritchon S; Asavatanabodee P; Koolvisoot A; Nanagara R; Totemchokchyakarn K; Nuntirooj K; Kitumnuaypong T
    Int J Rheum Dis; 2017 Sep; 20(9):1166-1184. PubMed ID: 28730640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.
    Alhajeri H; Abutiban F; Al-Adsani W; Al-Awadhi A; Aldei A; AlEnizi A; Alhadhood N; Al-Herz A; Alkandari W; Dehrab A; Muhanna Ghanem AA; Hasan E; Hayat S; Saleh K; Tarakmeh H; Ali Y
    Rheumatol Int; 2019 Sep; 39(9):1483-1497. PubMed ID: 31309293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis.
    Katchamart W; Bourré-Tessier J; Donka T; Drouin J; Rohekar G; Bykerk VP; Haraoui B; Leclerq S; Mosher DP; Pope JE; Shojania K; Thomson J; Thorne JC; Bombardier C;
    J Rheumatol; 2010 Jul; 37(7):1422-30. PubMed ID: 20516029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis.
    Lau CS; Chia F; Dans L; Harrison A; Hsieh TY; Jain R; Jung SM; Kishimoto M; Kumar A; Leong KP; Li Z; Lichauco JJ; Louthrenoo W; Luo SF; Mu R; Nash P; Ng CT; Suryana B; Wijaya LK; Yeap SS
    Int J Rheum Dis; 2019 Mar; 22(3):357-375. PubMed ID: 30809944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.
    Aletaha D; Eberl G; Nell VP; Machold KP; Smolen JS
    Ann Rheum Dis; 2002 Jul; 61(7):630-4. PubMed ID: 12079906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2016 update of the EULAR recommendations for the management of early arthritis.
    Combe B; Landewe R; Daien CI; Hua C; Aletaha D; Álvaro-Gracia JM; Bakkers M; Brodin N; Burmester GR; Codreanu C; Conway R; Dougados M; Emery P; Ferraccioli G; Fonseca J; Raza K; Silva-Fernández L; Smolen JS; Skingle D; Szekanecz Z; Kvien TK; van der Helm-van Mil A; van Vollenhoven R
    Ann Rheum Dis; 2017 Jun; 76(6):948-959. PubMed ID: 27979873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety.
    Favalli EG; Caporali R; Sinigaglia L; Pipitone N; Miniati I; Montecucco C; Matucci-Cerinic M;
    Clin Exp Rheumatol; 2011; 29(3 Suppl 66):S15-27. PubMed ID: 21906424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of French society for rheumatology recommendations for managing rheumatoid arthritis.
    Daien C; Hua C; Gaujoux-Viala C; Cantagrel A; Dubremetz M; Dougados M; Fautrel B; Mariette X; Nayral N; Richez C; Saraux A; Thibaud G; Wendling D; Gossec L; Combe B
    Joint Bone Spine; 2019 Mar; 86(2):135-150. PubMed ID: 30315988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety.
    Bombardier C; Hazlewood GS; Akhavan P; Schieir O; Dooley A; Haraoui B; Khraishi M; Leclercq SA; Légaré J; Mosher DP; Pencharz J; Pope JE; Thomson J; Thorne C; Zummer M; Gardam MA; Askling J; Bykerk V;
    J Rheumatol; 2012 Aug; 39(8):1583-602. PubMed ID: 22707613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy.
    Caporali R; Conti F; Alivernini S; Atzeni F; Seriolo B; Cutolo M; Valesini G; Ferraccioli G; Sarzi-Puttini P; Salvarani C; Guiducci S; Zampogna G; Gremese E; Pipitone N; Scrivo R; Bugatti S; Montecucco C; Matucci-Cerinic M;
    Clin Exp Rheumatol; 2011; 29(3 Suppl 66):S7-14. PubMed ID: 21906423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
    Albrecht K; Krüger K; Wollenhaupt J; Alten R; Backhaus M; Baerwald C; Bolten W; Braun J; Burkhardt H; Burmester GR; Gaubitz M; Gause A; Gromnica-Ihle E; Kellner H; Kuipers J; Krause A; Lorenz HM; Manger B; Nüßlein H; Pott HG; Rubbert-Roth A; Schneider M; Specker C; Schulze-Koops H; Tony HP; Wassenberg S; Müller-Ladner U;
    Rheumatol Int; 2014 Jan; 34(1):1-9. PubMed ID: 23942828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid arthritis referrals and rheumatologist scarcity: a prioritization tool.
    Cummins LL; Vangaveti V; Roberts LJ
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):326-31. PubMed ID: 25156328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence.
    Muñoz-Fernández S; Otón-Sánchez T; Carmona L; Calvo-Alén J; Escudero A; Narváez J; Rodríguez Heredia JM; Romero Yuste S; Vela P; Luján Valdés S; Royo García A; Baquero JL
    Rheumatol Int; 2018 Dec; 38(12):2289-2296. PubMed ID: 30251128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.
    Visser K; Katchamart W; Loza E; Martinez-Lopez JA; Salliot C; Trudeau J; Bombardier C; Carmona L; van der Heijde D; Bijlsma JW; Boumpas DT; Canhao H; Edwards CJ; Hamuryudan V; Kvien TK; Leeb BF; Martín-Mola EM; Mielants H; Müller-Ladner U; Murphy G; Østergaard M; Pereira IA; Ramos-Remus C; Valentini G; Zochling J; Dougados M
    Ann Rheum Dis; 2009 Jul; 68(7):1086-93. PubMed ID: 19033291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria.
    van der Heijde D; van der Helm-van Mil AH; Aletaha D; Bingham CO; Burmester GR; Dougados M; Emery P; Felson D; Knevel R; Kvien TK; Landewé RB; Lukas C; McInnes I; Silman AJ; Smolen JS; Stanislawska-Biernat E; Zink A; Combe B
    Ann Rheum Dis; 2013 Apr; 72(4):479-81. PubMed ID: 23378540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].
    Ndongo S; Pouye A; Lekpa FK; Bihéhé DM; Tiendrebeogo J; Ndao AC; Ka MM; Moreira Diop T
    Med Sante Trop; 2012; 22(4):385-9. PubMed ID: 23352953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
    Agca R; Heslinga SC; Rollefstad S; Heslinga M; McInnes IB; Peters MJ; Kvien TK; Dougados M; Radner H; Atzeni F; Primdahl J; Södergren A; Wallberg Jonsson S; van Rompay J; Zabalan C; Pedersen TR; Jacobsson L; de Vlam K; Gonzalez-Gay MA; Semb AG; Kitas GD; Smulders YM; Szekanecz Z; Sattar N; Symmons DP; Nurmohamed MT
    Ann Rheum Dis; 2017 Jan; 76(1):17-28. PubMed ID: 27697765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
    Singh JA; Saag KG; Bridges SL; Akl EA; Bannuru RR; Sullivan MC; Vaysbrot E; McNaughton C; Osani M; Shmerling RH; Curtis JR; Furst DE; Parks D; Kavanaugh A; O'Dell J; King C; Leong A; Matteson EL; Schousboe JT; Drevlow B; Ginsberg S; Grober J; St Clair EW; Tindall E; Miller AS; McAlindon T;
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):1-25. PubMed ID: 26545825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria.
    van der Linden MP; Knevel R; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2011 Jan; 63(1):37-42. PubMed ID: 20967854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.